3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
28
Melanoma
25
Carcinoma, Renal Cell
22
Lung Neoplasms
11
Neoplasm Metastasis
10
Squamous Cell Carcinoma of Head and Neck
9
Neoplasms
9
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Hodgkin Disease
8
Carcinoma, Transitional Cell
7
Carcinoma, Hepatocellular
7
Adenocarcinoma Of Esophagus
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Rectal Neoplasms
6
Ovarian Neoplasms
6
Pancreatic Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Nasopharyngeal Carcinoma
4
Multiple Myeloma
4
Endometrial Neoplasms
4
Carcinoma, Merkel Cell
4
Carcinoma, Basal Cell
4
Brain Neoplasms
4
Anus Neoplasms
4
Thyroid Neoplasms
3
Sarcoma, Kaposi
3
Recurrence
3
Interventions
Fulvestrant
2
tivozanib
1
ribociclib
1
palbociclib
1
niraparib
1
lorlatinib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Tamoxifen
1
STX-478
1
Metformin
1
Letrozole
1
Imlunestrant
1
Cetuximab
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Nivolumab
×
30 days
×
Clear all
No trials found.